NBIX

Neurocrine Biosciences, Inc.NASDAQHealthcare

$131.60-0.72%ClosedMarket Cap: $13.21B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-12	JP Morgan	—	Overweight	—
2026-02-17	Truist Securities	—	Buy	—
2026-02-13	Wells Fargo	—	Overweight	—
2026-02-12	BMO Capital	—	Market Perform	—
2026-02-12	Citigroup	—	Buy	—
2026-02-12	HC Wainwright & Co.	—	Buy	—
2026-02-12	RBC Capital	—	Outperform	—
2026-02-12	Needham	—	Buy	—
2026-02-12	Wedbush	—	Outperform	—
2026-01-23	UBS	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$7.69	$3.80B	13
Sun Dec 31	$10.03	$4.20B	16
Mon Dec 31	$10.61	$4.31B	14
Tue Dec 31	$12.44	$4.64B	14